Industry Growth Insights published a new data on “Molecular Diagnostics Cancer Market”. The research report is titled “Molecular Diagnostics Cancer Market research by Types (Pharmacogenomic Diagnosis, Liquid Biopsy, Other), By Applications (Respiratory Cancer, Cancer of Digestive System, Cancer of Urinary System, Cancer of Circulatory System, Motor System Cancer, Reproductive System Cancer, Other), By Players/Companies Roche, Danaher, Siemens, Abbott Laboratories, ICON Plc, AstraZeneca, MDxHealth, Invitae, PlexBio, Thermo Fisher Scientific, Guardant Health, Biocartis, Bio-Techne, Merck, Foundation Medicine, 10X Genomics, Biodesix, CytoTrack, GenomOncology, Luminex”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Molecular Diagnostics Cancer Market Research Report
By Type
Pharmacogenomic Diagnosis, Liquid Biopsy, Other
By Application
Respiratory Cancer, Cancer of Digestive System, Cancer of Urinary System, Cancer of Circulatory System, Motor System Cancer, Reproductive System Cancer, Other
By Companies
Roche, Danaher, Siemens, Abbott Laboratories, ICON Plc, AstraZeneca, MDxHealth, Invitae, PlexBio, Thermo Fisher Scientific, Guardant Health, Biocartis, Bio-Techne, Merck, Foundation Medicine, 10X Genomics, Biodesix, CytoTrack, GenomOncology, Luminex
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Molecular Diagnostics Cancer Market Report Segments:
The global Molecular Diagnostics Cancer market is segmented on the basis of:
Types
Pharmacogenomic Diagnosis, Liquid Biopsy, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Respiratory Cancer, Cancer of Digestive System, Cancer of Urinary System, Cancer of Circulatory System, Motor System Cancer, Reproductive System Cancer, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Danaher
- Siemens
- Abbott Laboratories
- ICON Plc
- AstraZeneca
- MDxHealth
- Invitae
- PlexBio
- Thermo Fisher Scientific
- Guardant Health
- Biocartis
- Bio-Techne
- Merck
- Foundation Medicine
- 10X Genomics
- Biodesix
- CytoTrack
- GenomOncology
- Luminex
Highlights of The Molecular Diagnostics Cancer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pharmacogenomic Diagnosis
- Liquid Biopsy
- Other
- By Application:
- Respiratory Cancer
- Cancer of Digestive System
- Cancer of Urinary System
- Cancer of Circulatory System
- Motor System Cancer
- Reproductive System Cancer
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Molecular Diagnostics Cancer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Molecular diagnostics cancer is a type of cancer that can be diagnosed through the use of molecular tests. Molecular diagnostics cancers are cancers that have specific changes in the DNA or RNA molecules.
Some of the key players operating in the molecular diagnostics cancer market are Roche, Danaher, Siemens, Abbott Laboratories, ICON Plc, AstraZeneca, MDxHealth, Invitae, PlexBio, Thermo Fisher Scientific, Guardant Health, Biocartis, Bio-Techne, Merck, Foundation Medicine, 10X Genomics, Biodesix, CytoTrack, GenomOncology, Luminex.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Molecular Diagnostics Cancer Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Molecular Diagnostics Cancer Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Molecular Diagnostics Cancer Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Molecular Diagnostics Cancer Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Molecular Diagnostics Cancer Market Size & Forecast, 2018-2028
4.5.1 Molecular Diagnostics Cancer Market Size and Y-o-Y Growth
4.5.2 Molecular Diagnostics Cancer Market Absolute $ Opportunity
Chapter 5 Global Molecular Diagnostics Cancer Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Molecular Diagnostics Cancer Market Size Forecast by Type
5.2.1 Pharmacogenomic Diagnosis
5.2.2 Liquid Biopsy
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Molecular Diagnostics Cancer Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Molecular Diagnostics Cancer Market Size Forecast by Applications
6.2.1 Respiratory Cancer
6.2.2 Cancer of Digestive System
6.2.3 Cancer of Urinary System
6.2.4 Cancer of Circulatory System
6.2.5 Motor System Cancer
6.2.6 Reproductive System Cancer
6.2.7 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Molecular Diagnostics Cancer Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Molecular Diagnostics Cancer Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Molecular Diagnostics Cancer Analysis and Forecast
9.1 Introduction
9.2 North America Molecular Diagnostics Cancer Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Molecular Diagnostics Cancer Market Size Forecast by Type
9.6.1 Pharmacogenomic Diagnosis
9.6.2 Liquid Biopsy
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Molecular Diagnostics Cancer Market Size Forecast by Applications
9.10.1 Respiratory Cancer
9.10.2 Cancer of Digestive System
9.10.3 Cancer of Urinary System
9.10.4 Cancer of Circulatory System
9.10.5 Motor System Cancer
9.10.6 Reproductive System Cancer
9.10.7 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Molecular Diagnostics Cancer Analysis and Forecast
10.1 Introduction
10.2 Europe Molecular Diagnostics Cancer Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Molecular Diagnostics Cancer Market Size Forecast by Type
10.6.1 Pharmacogenomic Diagnosis
10.6.2 Liquid Biopsy
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Molecular Diagnostics Cancer Market Size Forecast by Applications
10.10.1 Respiratory Cancer
10.10.2 Cancer of Digestive System
10.10.3 Cancer of Urinary System
10.10.4 Cancer of Circulatory System
10.10.5 Motor System Cancer
10.10.6 Reproductive System Cancer
10.10.7 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Molecular Diagnostics Cancer Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Molecular Diagnostics Cancer Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Molecular Diagnostics Cancer Market Size Forecast by Type
11.6.1 Pharmacogenomic Diagnosis
11.6.2 Liquid Biopsy
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Molecular Diagnostics Cancer Market Size Forecast by Applications
11.10.1 Respiratory Cancer
11.10.2 Cancer of Digestive System
11.10.3 Cancer of Urinary System
11.10.4 Cancer of Circulatory System
11.10.5 Motor System Cancer
11.10.6 Reproductive System Cancer
11.10.7 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Molecular Diagnostics Cancer Analysis and Forecast
12.1 Introduction
12.2 Latin America Molecular Diagnostics Cancer Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Molecular Diagnostics Cancer Market Size Forecast by Type
12.6.1 Pharmacogenomic Diagnosis
12.6.2 Liquid Biopsy
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Molecular Diagnostics Cancer Market Size Forecast by Applications
12.10.1 Respiratory Cancer
12.10.2 Cancer of Digestive System
12.10.3 Cancer of Urinary System
12.10.4 Cancer of Circulatory System
12.10.5 Motor System Cancer
12.10.6 Reproductive System Cancer
12.10.7 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Molecular Diagnostics Cancer Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Molecular Diagnostics Cancer Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Molecular Diagnostics Cancer Market Size Forecast by Type
13.6.1 Pharmacogenomic Diagnosis
13.6.2 Liquid Biopsy
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Molecular Diagnostics Cancer Market Size Forecast by Applications
13.10.1 Respiratory Cancer
13.10.2 Cancer of Digestive System
13.10.3 Cancer of Urinary System
13.10.4 Cancer of Circulatory System
13.10.5 Motor System Cancer
13.10.6 Reproductive System Cancer
13.10.7 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Molecular Diagnostics Cancer Market: Competitive Dashboard
14.2 Global Molecular Diagnostics Cancer Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 Danaher
14.3.3 Siemens
14.3.4 Abbott Laboratories
14.3.5 ICON Plc
14.3.6 AstraZeneca
14.3.7 MDxHealth
14.3.8 Invitae
14.3.9 PlexBio
14.3.10 Thermo Fisher Scientific
14.3.11 Guardant Health
14.3.12 Biocartis
14.3.13 Bio-Techne
14.3.14 Merck
14.3.15 Foundation Medicine
14.3.16 10X Genomics
14.3.17 Biodesix
14.3.18 CytoTrack
14.3.19 GenomOncology
14.3.20 Luminex
